Manjula Ananthram, MD
Advanced Heart Failure and Transplant Cardiology · Norfolk, VANPI 1164549523
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,355 of the $5,145 with a category attached, or 65.2%. UCB, Inc. accounts for 65.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $4,507, more than ten times the $47 reported in 2020.
Across 22 payments — averaging $233.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- Abbott$2K
- One Lambda, Inc.$65
- Teleflex LLC$60
- Medtronic$47
Across 24 payments — averaging $21,957 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endotronix, Inc.$470K
- Medtronic$32K
- E.r. Squibb & Sons, L.L.C.$22K
- Novartis$3K
What the payments were for
- Consulting fees$3,35565%
- Travel & lodging$65213%
- Food & beverage$1,13822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 1 | $3,355 |
| Abbott | 16 | $1,618 |
| One Lambda, Inc. | 2 | $65 |
| Teleflex LLC | 1 | $60 |
| Medtronic | 2 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,145 in reported general payments places this provider in the 55th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.
See all advanced heart failure and transplant cardiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 62 | $63,310 |
| EntrestoSacubitril/Valsartan | 47 | $56,231 |
| EliquisApixaban | 24 | $33,319 |
| XareltoRivaroxaban | 27 | $23,560 |
| FarxigaDapagliflozin Propanediol | 16 | $8,402 |
| Amiodarone Hcl | 24 | $1,042 |
| Eplerenone | 18 | $932 |
| Candesartan Cilexetil | 13 | $902 |
| Metoprolol Succinate | 65 | $673 |
| Spironolactone | 85 | $647 |
| Torsemide | 34 | $538 |
| Atorvastatin Calcium | 42 | $384 |
| Potassium Chloride | 12 | $263 |
| Hydralazine Hcl | 26 | $241 |
| Furosemide | 42 | $206 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Norfolk
- Amin YehyaNorfolk$398K
- Raymond BenzaNorfolk$141K
- Zackary TushakNorfolk$92K
- Robert BernsteinNorfolk$73
- John HerreChesapeake$270K
- Palak ShahFalls Church$112K
- Shashank DesaiFalls Church$80K
- Keyur ShahRichmond,$62K
- Mirnela BykuCharlottesville$62K
- Edward SaweyRichmond$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.